Dental equipment and technology provider Convergent Dental has received approval from the US Food and Drug Administration (FDA) for its CO2 laser technology system called Solea, which is used for cutting hard and soft tissues in the oral cavity.
Claimed to be the world’s first CO2 laser technology system, Solea is a silent, vibration-free 9.3µm wavelength CO2 computer-aided preparation (CAP) dental laser system.
The system uses pulsed energy and other technologies to cut hard tissue and perform incision, excision, vaporisation, coagulation and hemostasis of soft tissue in the oral cavity.
Moreover, the system is so fast that it does not require a drill to cut smooth margins, either between teeth or decayed enamel.
Solea’s computer-controlled mirrors are capable of moving 10,000 times each second, distributing a defined beam in particular patterns that augument speed and precision of cutting.
Dentists can control the speed of cutting with the help of the foot pedal in the system, a feature said to be lacking with advanced laser technology in the market.
Convergent Dental CEO Michael Cataldo said: "Receiving FDA clearance for hard tissue indications allows dentists to put the drill away for the vast majority of hard tissue procedures for the first time, and even more importantly eliminates the notorious drill-dread anxiety for patients."
Boston Center for Oral Health Boston associate dean for research Dr Gerard Kugel noted that research indicates that Solea’s wavelength will deliver six times faster cutting speed and more precision than any erbium laser.
"Based upon my experience with the system, I fully expect that Solea will modernise the practice of dentistry in the removal of decay and helping to prevent it in the first place," Kugel said.
Meanwhile, the firm also announced the completion of Series A and B funding rounds, totaling more than $13.5m.